{
    "clinical_study": {
        "@rank": "100798", 
        "arm_group": {
            "arm_group_label": "3D sonographic analysis", 
            "description": "The study is designed to evaluate a new imaging modality, 3D sonographic volumetric analysis, and compare it to the conventional 2-dimmensional analysis that is currently in place.  Those patients who are scheduled to have an ultrasound as part of their infertility treatment will be offered the opportunity to have additional measurements done at the time of their ultrasound; these additional measurements will take less than 2 minutes and do no require any additional sonograms, tests, or interventions."
        }, 
        "brief_summary": {
            "textblock": "The study is designed to evaluate a new imaging modality, 3-dimmensional sonographic\n      volumetric analysis, and compare it to the conventional 2-dimmensional analysis that is\n      currently in place.  Those patients who are scheduled to have an ultrasound as part of their\n      infertility treatment will be offered the opportunity to have additional measurements done\n      at the time of their ultrasound; these additional measurements will take less than 2 minutes\n      and do no require any additional sonograms, tests, or interventions.  All patients are\n      eligible (oocyte donors and autologous oocyte patients) and only patients with a serum\n      estradiol > 2000pg/ML will be enrolled in the study.  After the additional measurements are\n      obtained, the results will be digitally stored.  The results of the 3D sonographic\n      volumetric analysis will then be correlated with the patients' IVF performance."
        }, 
        "brief_title": "3 Dimensional Sonography Imaging", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "The Focus of Study Will be on a New Imaging Modality.", 
        "detailed_description": {
            "textblock": "The benefits of the study is that 3-dimensional sonographic volumetric analysis may be a\n      superior imaging modality for sonographically assessing oocyte maturity and may lead to\n      change in clinical practice.  The lone risk of the study is rooted in protecting the\n      patients' protected health information."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients (oocyte donors and autologous oocyte patients)with a serum estradiol >\n             2000pg/ML.\n\n        Exclusion Criteria:\n\n          -  All patients not meeting the estradiol criteria."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "In Vitro fertilization patients and donor egg patients of the Ronald O. Perelman and\n        Claudia Cohen Center for Reproductive Medicine who at the day of monitoring (having an\n        ultrasound and blood work drawn) have an estradiol level greater than 2000pg/ML."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01872559", 
            "org_study_id": "1209013095"
        }, 
        "intervention": {
            "arm_group_label": "3D sonographic analysis", 
            "description": "Those patients who are scheduled to have an ultrasound as part of their infertility treatment will be offered the opportunity to have additional measurements done at the time of their ultrasound; these additional measurements will take less than 2 minutes and do not require any additional sonograms, tests, or interventions.", 
            "intervention_name": "3D Sonography analysis", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "contact": {
                "email": "mij2008@med.cornell.edu", 
                "last_name": "Mitasha C Joseph, RN, MPA", 
                "phone": "646-962-3382"
            }, 
            "contact_backup": {
                "email": "res2011@med.cornell.edu", 
                "last_name": "Rodriq E Stubbs, NP", 
                "phone": "646-962-3276"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "Weill Cornell Medical College"
            }, 
            "investigator": {
                "last_name": "Glenn Schattman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "3D Sonographic Volumetric Analysis of Ovarian Follicles.", 
        "overall_official": {
            "affiliation": "Weill Medical College of Cornell University", 
            "last_name": "Glenn Schattman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlations for age of patient, BMI, documented 2-dimensional sonographic analysis, type of oocyte maturation trigger, serum estradiol prior to trigger, serum estradiol after trigger, number of oocyte retrieved, number of mature oocytes retrieved, embryo grade, type of incubator utilized, day 3 or day 5 transfer, implantation rate, and ultimate pregnancy will be made with the volumetric analysis.", 
            "measure": "IVF performance", 
            "safety_issue": "No", 
            "time_frame": "3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01872559"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Weill Medical College of Cornell University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}